Incidence of postoperative delirium and quality of recovery in older patients undergoing gastrectomy under general anaesthesia with remimazolam vs. propofol: a randomised non-inferiority study
- PMID: 40653956
- DOI: 10.1111/anae.16684
Incidence of postoperative delirium and quality of recovery in older patients undergoing gastrectomy under general anaesthesia with remimazolam vs. propofol: a randomised non-inferiority study
Abstract
Introduction: Due to its haemodynamic stability and rapid recovery from anaesthesia, remimazolam is an attractive hypnotic drug for general anaesthesia in older patients. However, remimazolam must show non-inferiority in terms of the incidence of delirium and quality of postoperative recovery to be used as an alternative to propofol for maintenance of general anaesthesia.
Methods: Patients aged ≥ 65 y scheduled to undergo gastrectomy were randomly allocated to maintenance of general anaesthesia with a remimazolam infusion (remimazolam group) or propofol target-controlled infusion (propofol group) in a 1:1 ratio. The primary outcome measure was the incidence of delirium within 72 h of surgery (assessed using the confusion assessment method). Secondary outcomes included the quality of recovery at 24 h postoperatively (assessed using the translated Korean version of the 15-item Quality of Recovery questionnaire) and the incidence of postoperative nausea, retching and vomiting.
Results: Of 461 patients randomly allocated in the study, 432 were included in the analysis (216 in each group). The incidence of delirium was 17/216 (7.9%) in patients allocated to the remimazolam group and 17/216 (7.9%) in those allocated to the propofol group (unadjusted odds ratio 1.00, 95%CI 0.50-2.02, p = 1.000). Quality of recovery scores were also similar between groups at 24 h postoperatively (median (IQR [range]) 109 (102-115 [54-140]) vs. 109 (104-115 [70-137]) for the remimazolam and propofol groups, respectively (p = 0.627); unadjusted odds ratio -0.03, 95%CI -0.19-0.13).
Discussion: Remimazolam can be used as an alternative to propofol in older patients undergoing gastrectomy from the perspective of the incidence of postoperative delirium and quality of recovery.
Keywords: anaesthesia; delirium; older; propofol; remimazolam.
© 2025 Association of Anaesthetists.
References
-
- Pereira EM, Moraes VR, Gaya da Costa M, Nascimento TS, Slawka E, Júnior CG, Struys MMRF Remimazolam vs. propofol for general anaesthesia in elderly patients: a meta‐analysis with trial sequential analysis. Eur J Anaesthesiol 2024; 41: 738–48. https://doi.org/10.1097/EJA.0000000000002042
-
- Hu Q, Liu X, Wen C, Li D, Lei X. Remimazolam: an updated review of a new sedative and anaesthetic. Drug Des Devel Ther 2022; 16: 3957–3974. https://doi.org/10.2147/DDDT.S384155.
-
- Arias JA, Wegner GRM, Wegner BFM, Silva LS, Bezerra FJL, Filardi RGM. Association of remimazolam with delirium and cognitive function: a systematic review and meta‐analysis of randomised controlled trials. Eur J Anaesthesiol 2025; 42: 285–297. https://doi.org/10.1097/EJA.0000000000002107.
-
- Kim H, Min BK, Lee U, Sim JH, Noh GJ, Lee EK, Choi BM. Electroencephalographic features of elderly patients during anesthesia induction with remimazolam: a substudy of a randomized controlled trial. Anesthesiology 2024; 141: 681–692. https://doi.org/10.1097/ALN.0000000000004904.
-
- Schnider TW, Minto CF, Gambus PL, Andresen C, Goodale DB, Shafer SL, Youngs EJ. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998; 88: 1170–1182.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
